Skip to content

observational clinical trial on burn patients

AN OBSERVATIONAL STUDY TO ASSESS INFLAMMATION IN BURN PATIENTS BY IL-6 DETECTION THROUGH RT- PCR TECHNIQUE FROM BLOOD AND SALIVA VS CHEMI-LUMINESCENT IMMUNOASSAY (CLIA) TECHNIQUE FROM BLOOD

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/02/031468
Enrollment
50
Registered
2021-02-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: T222- Burn of second degree of shoulderand upper limb, except wrist and hand

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Zum Heilen Diagnostic Therapeutics ZH DT
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age group 19 â?? 70 yrs 2.Both male and females involved 3.Burns with • Subjects who are willing to provide written consent for the study 4.Subjects willing to abide by and comply with the study protocol

Exclusion criteria

Exclusion criteria: 1.Patients above 70yrs old and also those with greater than 50% burn 2.Pregnancy and lactation 3.Other health conditions, which in the opinion of the investigators makes the patient unsuitable for enrolment or could interfere in adherence to of the study protocol

Design outcomes

Primary

MeasureTime frame
· Change in IL-6 at transcriptional and translational level using RT-PCR analysis and CLIA analysis in relation to development of Sepsis from baseline to the end of study Timepoint: Day 0,Day 3 and Day 5

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Prashanth Varkey

Zum Heilen Diagnostic and Therapeutics

drpvarkey@gmail.com9249584682

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026